Nationwide Fund Advisors - WUXI PHARMATECH CAYMAN INC ownership

WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 157 filers reported holding WUXI PHARMATECH CAYMAN INC in Q3 2014. The put-call ratio across all filers is 1.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
Nationwide Fund Advisors ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q2 2015$834,000
-61.9%
19,730
-65.1%
0.00%
-66.7%
Q1 2015$2,190,000
+31.1%
56,473
+13.9%
0.01%
+28.6%
Q4 2014$1,670,000
+13.5%
49,600
+18.0%
0.01%
+16.7%
Q3 2014$1,472,000
-25.0%
42,040
-21.0%
0.01%
-33.3%
Q1 2014$1,962,000
-40.1%
53,240
-37.6%
0.01%
-35.7%
Q4 2013$3,275,000
+34.5%
85,330
-4.0%
0.01%
+27.3%
Q3 2013$2,435,000
-12.4%
88,880
-32.8%
0.01%
-26.7%
Q2 2013$2,779,000132,3100.02%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q3 2014
NameSharesValueWeighting ↓
Coupland Cardiff Asset Management LLP 261,361$8,588,0006.86%
Black Creek Investment Management Inc. 1,644,485$54,038,0005.68%
Consonance Capital Management LP 1,143,315$37,569,0005.59%
Sloane Robinson LLP 120,000$3,943,0002.47%
THOMAS WHITE INTERNATIONAL LTD 470,769$15,469,0002.16%
Grandeur Peak Global Advisors, LLC 295,035$9,695,0002.09%
Mirae Asset Global Investments Co., Ltd. 2,370,406$77,891,0001.73%
Granite Point Capital Management, L.P. 70,000$2,300,0001.58%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 89,810$2,951,0001.38%
COMMONWEALTH BANK OF AUSTRALIA 2,626,749$86,315,0001.16%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders